FUB-JWH-018
 | |
| Systematic (IUPAC) name | |
|---|---|
|
(1-(4-fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | |
| Clinical data | |
| Legal status |
|
| Chemical data | |
| Formula | C26H18FNO |
| Molar mass | 379.43 g/mol |
| |
| |
FUB-JWH-018 (also known as FUB-018) is an indole-based synthetic cannabinoid, representing a molecular hybrid of JWH-018 and AB-FUBICA or ADB-FUBICA.[1]
Legal Status
As of October 2015 FUB-JWH-018 is a controlled substance in China.[2]
See also
- AB-FUBINACA
- ADB-FUBINACA
- AMB-FUBINACA
- FUB-144
- FUB-APINACA
- FUB-NNE1
- FDU-PB-22
- FUB-PB-22
- MDMB-FUBICA
- MDMB-FUBINACA
References
- ↑ "FUB-JWH 018". Cayman Chemical. Retrieved 8 July 2015.
- ↑ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Friday, February 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.